Plasmid DNA-based gene transfer with ultrasound and microbubbles

Current Gene Therapy

Volumn 11, Issue 6, 2011, Pages 485-490

  Taniyama, Yoshiaki ^a   Azuma, Junya ^a   Rakugi, Hiromi ^a   Morishita, Ryuichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Cavitation; Gene therapy; Microbubble; Peripheral artery disease (PAD); Ultrasound

Indexed keywords

CATION; FIBROBLAST GROWTH FACTOR; PHOSPHOLIPID; PLASMID DNA; SCATTER FACTOR;

AMPUTATION; ANGIOGENESIS; ANGIOGENIC GENE THERAPY; ARTICLE; GENE TRANSFER; HUMAN; ISCHEMIA; LIMB SALVAGE; MICROBUBBLE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RISK ASSESSMENT; SURVIVAL RATE; ULTRASOUND;

CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; MICROBUBBLES; PERIPHERAL ARTERIAL DISEASE; PLASMIDS; TRANSFECTION; ULTRASONOGRAPHY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 82055198565     PISSN: 15665232     EISSN: 18755631     Source Type: Journal    
DOI: 10.2174/156652311798192851     Document Type: Article

References (52)

1. Check E. Gene therapy: shining hopes dented-but not dashed. Nature 2002; 420 (6917): 735.
2. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999; 286(5448): 2244-5.
3. Second. Second European Consensus Document on chronic critical leg ischemia. Circulation 1991; 84 (4 Suppl): IV1-26.
4. Dormandy J, Mahir M, Ascady G, et al. Fate of the patient with chronic leg ischaemia. A review article. J Cardiovasc Surg (Torino) 1989; 30 (1): 50-57.
5. Rutherford R. Suggested standards for reports dealing with lower extremity ischemia. Prepared by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg 1986; 4 (1): 80-94.
6. Kusumanto YH, van Weel V, Mulder NH, et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Hum Gene Ther 2006; 17 (6): 683-91.
7. Rajagopalan S, Mohler ER, 3rd, Lederman RJ, et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 2003; 108 (16): 1933-8.
8. Nikol S, Baumgartner I, Van Belle E, et al. Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol Ther 2008; 16 (5): 972-8.
9. Grossman PM, Mendelsohn F, Henry TD, et al. Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease. Am Heart J 2007; 153(5): 874-80.
10. Powell RJ, Simons M, Mendelsohn FO, et al. Results of a doubleblind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation 2008; 118(1): 58-65.
11. Sanofi-aventis. Sanofi-aventis, Clinical up date on TAMARIS phase III trial for NV1FGF, press release, September 22, 2010. Available at 2010.
12. Shigematsu H, Yasuda K, Iwai T, et al. Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia. Gene Ther 2010; 17(9): 1152-61.
13. Ueno H, Li JJ, Masuda S, et al. Adenovirus-mediated expression of the secreted form of basic fibroblast growth factor (FGF-2) induces cellular proliferation and angiogenesis in vivo. Arterioscler Thromb Vasc Biol 1997; 17(11): 2453-60.
14. Takahashi JC, Saiki M, Miyatake S, et al. Adenovirus-mediated gene transfer of basic fibroblast growth factor induces in vitro angiogenesis. Atherosclerosis 1997; 132(2): 199-205.
15. Giordano FJ, Ping P, McKirnan MD, et al. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat Med 1996; 2(5): 534-9.
16. Schwarzacher SP, Uren NG, Ward MR, et al. Determinants of coronary remodeling in transplant coronary disease: a simultaneous intravascular ultrasound and Doppler flow study. Circulation 2000; 101(12): 1384-9.
17. Gowdak LH, Poliakova L, Wang X, et al. Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia. Circulation 2000; 102(5): 565-71.
18. Dzau VJ, Mann MJ, Morishita R, et al. Fusigenic viral liposome for gene therapy in cardiovascular diseases. Proc Natl Acad Sci USA 1996; 93(21): 11421-5.
19. Tachibana K, Uchida T, Ogawa K, et al. Induction of cellmembrane porosity by ultrasound. Lancet 1999; 353(9162): 1409.
20. Tachibana K, Tachibana S. Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis. Circulation 1995; 92(5): 1148-50.
21. Taniyama Y, Tachibana K, Hiraoka K, et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther 2002; 9(6): 372-80.
22. Taniyama Y, Tachibana K, Hiraoka K, et al. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002; 105(10): 1233-9.
23. Suzuki J, Ogawa M, Takayama K, et al. Ultrasound-microbubblemediated intercellular adhesion molecule-1 small interfering ribonucleic acid transfection attenuates neointimal formation after arterial injury in mice. J Am Coll Cardiol 2010; 55(9): 904-13.
24. Inagaki H, Suzuki J, Ogawa M, et al. Ultrasound-microbubblemediated NF-kappaB decoy transfection attenuates neointimal formation after arterial injury in mice. J Vasc Res 2006; 43(1): 12-8.
25. Shimamura M, Sato N, Taniyama Y, et al. Gene transfer into adult rat spinal cord using naked plasmid DNA and ultrasound microbubbles. J Gene Med 2005; 7(11): 1468-1474.
26. Koike H, Tomita N, Azuma H, et al. An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney. J Gene Med 2005; 7(1): 108-16.
27. Shimamura M, Sato N, Taniyama Y, et al. Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound. Gene Ther 2004; 11(20): 1532-9.
28. Hashiya N, Aoki M, Tachibana K, et al. Local delivery of E2F decoy oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model. Biochem Biophys Res Commun 2004; 317(2): 508-14.
29. Yang L, Shirakata Y, Tamai K, et al. Microbubble-enhanced ultrasound for gene transfer into living skin equivalents. J Dermatol Sci 2005; 40(2): 105-14.
30. Azuma H, Tomita N, Kaneda Y, et al. Transfection of NFkappaBdecoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts. Gene Ther 2003; 10(5): 415-25.
31. Endoh M, Koibuchi N, Sato M, et al. Fetal gene transfer by intrauterine injection with microbubble-enhanced ultrasound. Mol Ther 2002; 5(5 Pt 1): 501-8.
32. Grines CL, Watkins MW, Helmer G, et al. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation 2002; 105(11): 1291-7.
33. Grines CL, Watkins MW, Mahmarian JJ, et al. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J Am Coll Cardiol 2003; 42(8): 1339-1347.
34. Rajagopalan S, Olin J, Deitcher S, et al. Use of a constitutively active hypoxia-inducible factor-1alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I doseescalation experience. Circulation 2007; 115(10): 1234-43.
35. Fechheimer M, Boylan JF, Parker S, et al. Transfection of mammalian cells with plasmid DNA by scrape loading and sonication loading. Proc Natl Acad Sci USA 1987; 84(23): 8463-7.
36. Porter TR, Iversen PL, Li S, Xie F. Interaction of diagnostic ultrasound with synthetic oligonucleotide-labeled perfluorocarbonexposed sonicated dextrose albumin microbubbles. J Ultrasound Med 1996; 15(8): 577-84.
37. Bao S, Thrall BD, Miller DL. Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med Biol 1997; 23(6): 953-9.
38. Shohet RV, Chen S, Zhou YT, et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000; 101(22): 2554-6.
39. Feril LB, Jr., Kondo T, Zhao QL, et al. Enhancement of ultrasound-induced apoptosis and cell lysis by echo-contrast agents. Ultrasound Med Biol 2003; 29(2): 331-7.
40. Greenleaf WJ, Bolander ME, Sarkar G, et al. Artificial cavitation nuclei significantly enhance acoustically induced cell transfection. Ultrasound Med Biol 1998; 24(4): 587-95.
41. Suzuki G. Recent progress in plant reproduction research: the story of the male gametophyte through to successful fertilization. Plant Cell Physiol 2009; 50(11): 1857-64.
42. Unger EC, Hersh E, Vannan M, et al. Local drug and gene delivery through microbubbles. Prog Cardiovasc Dis 2001; 44(1): 45-4.
43. Kudo N, Okada K, Yamamoto K. Sonoporation by single-shot pulsed ultrasound with microbubbles adjacent to cells. Biophys J 2009; 96(12): 4866-76.
44. Tachibana K, Tachibana S. Transdermal delivery of insulin by ultrasonic vibration. J Pharm Pharmacol 1991; 43(4): 270-1.
45. Tachibana K, Tachibana S. Use of ultrasound to enhance the local anesthetic effect of topically applied aqueous lidocaine. Anesthesiology 1993; 78(6): 1091-6.
46. Tachibana K, Tachibana S. The use of ultrasound for drug delivery. Echocardiography 2001; 18(4): 323-8.
47. Li T, Tachibana K, Kuroki M. Gene transfer with echo-enhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice--initial results. Radiology 2003; 229(2): 423-8.
48. Bekeredjian R, Grayburn PA, Shohet RV. Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol 2005; 45(3): 329-35.
49. Vannan M, McCreery T, Li P, et al. Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA. J Am Soc Echocardiogr 2002; 15(3): 214-8.
50. Tsunoda S, Mazda O, Oda Y, et al. Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. Biochem Biophys Res Commun 2005; 336(1): 118-27.
51. Zen K, Okigaki M, Hosokawa Y, et al. Myocardium-targeted delivery of endothelial progenitor cells by ultrasound-mediated microbubble destruction improves cardiac function via an angiogenic response. J Mol Cell Cardiol 2006; 40(6): 799-809.
52. Mukherjee D, Wong J, Griffin B, et al. Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration. J Am Coll Cardiol 2000; 35(6): 1678-86.